Applying stem cells and directed cell fate - modulation for neurodegenerative disease research

Summarise with VIRAT
Authors: Carina Habich
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD) are becoming increasingly important considering the aging population. Despite the rising number of affected individuals, there are currently no effective therapies to combat the causes of the disease. Current treatments aim only at alleviating symptoms. Traditionally, only animal models or primary neuron cultures were available for research, and these approaches are limited for ethical and practical reasons. A promising solution is the use of human induced pluripotent stem cells (hiPSC). Their ability to differentiate into specialized cell types opens up great opportunities for modeling human diseases, drug screening and the development of personalized therapies. This dissertation addresses current challenges in research by developing new accelerated differentiation protocols for different neuron types suitable for high-throughput screening (HTS). Based on the work of Alexandra Kowalski’s Dissertation, the "BMWi" induction approach was established, which inhibits BMP, MEK, and WNT signaling pathways to differentiate telencephalic/cortical neurons and was further developed as part of my master's thesis. This resulted in the BMWi differentiation protocol, which is based on BMWi pre-differentiation followed by Neurogenin 2 (NGN2) overexpression. In this dissertation different induction paradigms were investigated to optimize neural induction by testing diverse combinations of inhibitors for BMP, TGFβ, FGF2, MEK, and WNT signaling pathways. The BMWi protocol demonstrated the fastest induction and outperformed common protocols such as dual SMAD inhibition (dSMADi) in efficiency. BMWi neurons were compared with dSMADi and iNGN2 neurons (neurons induced by NGN2 overexpression) by bulk RNA sequencing and showed both improved expression of key marker genes for telencephalic/cortical identity such as PAX6, TBR1, SLC16A6 and FOXG1 compared to iNGN2 neurons at the molecular level, as well as robust electrical activity. The identity of BMWi and dSMADi neurons was comparable with respect to telencephalic/cortical marker genes. BMWi differentiation resulted in a homogeneous neuron population that was clearly distinct from iNGN2 neurons. The neurons also oƯer the potential to model neurodegenerative diseases such as AD and PD. BMWi neurons exhibit the ability to mimic TAU aggregation, providing an effective model for drug screening. Various tool compounds were able to demonstrate comparable TAU clearance results in BMWi neurons as in the dSMADi neurons already established for TAU clearance screening assays. This model supports the identification of new therapeutic approaches for the treatment or prevention of AD.

Fields of Study & Subjects

Pluripotent Stem Cells Research Neurogenesis and neuroplasticity mechanisms Developmental Biology and Gene Regulation

Publication details

Journal / source
Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
Publication date
20 March 2026
Language
EN
Document type
Thesis